Effectiveness of sirolimus for early on‐set autoimmune cytopenias of autoimmune lymphoproliferative immunodeficiencies
Pediatric Allergy and Immunology · 2025-09 · 36 (9)
DOI: 10.1111/pai.70186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 02.09.2025. Verfasst von Hao Gu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, C…. Hauptthemen laut MEDLINE: Sirolimus, Immunosuppressive Agents, Anemia, Hemolytic, Autoimmune, Autoimmune Lymphoproliferative Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Beijing Hospitals Authority Clinical Medicine Development of Special Funding, National Key R&D Program of China, Chinese Institutes for Medical Research, Beijing.
Abstract (Originalsprache)
Background
Pediatric patients with autoimmune lymphoproliferative immunodeficiencies (ALPIDs) who exhibit autoimmune cytopenias are frequently diagnosed with immune thrombocytopenia (ITP), autoimmune hemolytic anemia (AIHA), or Evans syndrome (ES). These conditions generally necessitate long‐term immunosuppressive therapy using medications that are often ineffective and highly toxic before the diagnosis of ALPIDs. A less harmful treatment strategy is needed.
Methods
In this study, we described 23 pediatric patients whose initial symptom was autoimmune cytopenias and who were treated with sirolimus as monotherapy (1.5–4 years) upon being diagnosed with ALPIDs.
Results
Children with ALPIDs achieved a sustainable response in immune‐related cytopenias and lymphoproliferation manifestations within 3 months of sirolimus monotherapy. The complete response (CR) rate for cytopenias was higher compared to lymphoproliferative manifestations. Thrombocytopenia achieved CR more quickly than anemia and neutropenia. Following sirolimus treatment, there was an increase in the proportion of CD4 + CD25 + Foxp3 + Tregs and serum TGF‐β, while a significant reduction in the DNT ratio was observed.
Conclusion
Sirolimus resulted in CR and long‐lasting responses in most pediatric ALPIDs patients, suggesting it could be considered as a first line for patients requiring prolonged therapy. The increase in Tregs and decrease in DNT after sirolimus treatment may provide insights into the underlying mechanisms of sirolimus in ALPIDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
- Beijing Key Laboratory of Pediatric Hematology Oncology; Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health…
- Department of Hematology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
- Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Key Laboratory for Genetics of Birth Defects, Beijing, China.
Förderung
- Beijing Hospitals Authority Clinical Medicine Development of Special Funding
- National Key R&D Program of China
- Chinese Institutes for Medical Research, Beijing
- Beijing Hospitals Authority's Ascent Plan
- Beijing Municipal Natural Science Fundation
- National Key Research and Development Program of China
Zitieren
APA
Gu, H., Shu, Z., Chen, Z., Deng, M., Lu, D., Wu, R., Wang, T., & Mao, H. (2025). Effectiveness of sirolimus for early on‐set autoimmune cytopenias of autoimmune lymphoproliferative immunodeficiencies. Pediatric Allergy and Immunology, 36(9). https://doi.org/10.1111/pai.70186
Vancouver
Gu H, Shu Z, Chen Z, Deng M, Lu D, Wu R, et al. Effectiveness of sirolimus for early on‐set autoimmune cytopenias of autoimmune lymphoproliferative immunodeficiencies. Pediatric Allergy and Immunology. 2025;36(9). doi:10.1111/pai.70186
BibTeX
@article{Gu2025,
author = {Gu, Hao and Shu, Zhou and Chen, Zhenping and Deng, Mengyue and Lu, Dan and Wu, Runhui and Wang, Tianyou and Mao, Huawei},
title = {Effectiveness of sirolimus for early on‐set autoimmune cytopenias of autoimmune lymphoproliferative immunodeficiencies},
journal = {Pediatric Allergy and Immunology},
year = {2025},
volume = {36},
number = {9},
doi = {10.1111/pai.70186}
}
EUVIMED